Relative log abundance plots (within or across groups)

This analysis uses the 'RlaPlots' function of the 'Metabolomics' package in the R statistics environment
Click on links below to perform analysis.

Map	Study ID	Mode	Study Title	MS Analysis Type
	ST002011	Within groups Across groups	The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases.	Reversed phase NEGATIVE ION MODE
	ST002011	Within groups Across groups	The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases.	Reversed phase NEGATIVE ION MODE
	ST002011	Within groups Across groups	The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases.	Reversed phase NEGATIVE ION MODE